TrialOpen forum infectious diseases2025

Efficacy and Safety Outcomes in Adults Initiating Dolutegravir/Lamivudine With High Viral Load in the GEMINI-1/-2 and STAT Trials.

Charlotte-Paige Rolle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.